Loan Nguyen

Loan Nguyen

Auto-generated profile, based on publicly available information

Loan Nguyen

Faculty of Life Sciences, University of Manchester, Manchester, UK

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2013 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Open access
BRBeatriz Rodriguez-Grande
Beatriz Rodriguez-Grande
MSMatimba Swana
Matimba Swana
LNLoan Nguyen
Loan Nguyen
PEPavlos Englezou
Pavlos Englezou
Samaneh (Ella) MaysamiSamaneh (Ella) Maysami
Samaneh (Ella) Maysami
EPEmmanuel Pinteaux
Emmanuel Pinteaux
Acute-phase proteins (APPs) are key effectors of the immune response and are routinely used as biomarkers in cerebrovascular diseases, but their role during brain inflammation remains largely unknown. Elevated circulating levels of the acute-phase protein pentraxin-3 (PTX3) are associated with worse outcome in stroke patients. Here we show that PTX3 is expressed in neurons and glia in response to cerebral ischemia, and that the proinflammatory cytokine interleukin-1 (IL-1) is a key driver of PTX3 expression in the brain after experimental stroke. Gene deletion of PTX3 had no significant effects on acute ischemic brain injury. In contrast, the absence of PTX3 strongly compromised blood–brain barrier integrity and resolution of brain edema during recovery after ischemic injury. Compromised resolution of brain edema in PTX3-deficient mice was associated with impaired glial scar formation and alterations in scar-associated extracellular matrix production. Our results suggest that PTX3 expression induced by proinflammatory signals after ischemic brain injury is a critical effector of edema resolution and glial scar formation. This highlights the potential role for inflammatory molecules in brain recovery after injury and identifies APPs, in particular PTX3, as important targets in ischemic stroke and possibly other brain inflammatory disorders.

31 July 2010 in Molecular and Cellular Neuroscience
Verified
Journal Article
Open access
LSLauren Summers
Lauren Summers
KKKorakoch Kangwantas
Korakoch Kangwantas
LNLoan Nguyen
Loan Nguyen
CKCay Kielty
Cay Kielty
EPEmmanuel Pinteaux
Emmanuel Pinteaux
The extracellular matrix (ECM) of the brain is essential for homeostasis and normal functions, but is rapidly remodelled during acute brain injury alongside the development of an inflammatory response driven by the cytokine interleukin (IL)-1. Whether the ECM regulates IL-1 actions in astrocytes is completely unknown. The aim of this study was to test the hypothesis that cellular attachment to the ECM is a critical mediator of IL-1beta-induced signalling pathways and development of reactive phenotype in astrocytes. Primary rat astrocytes adhered to fibronectin, laminin and fibrillin-1 in an integrin-dependent manner. Attachment to these ECM molecules significantly increased IL-1beta-induced activation of extracellular signal-regulated kinase 1/2 (ERK1/2) and inhibition of RhoA and Rho kinase (ROCK), coincident with loss of focal adhesions and cellular morphological changes. Our data demonstrate that the ECM regulates IL-1 actions in astrocytes via cross-talk mechanisms between ERK1/2 and RhoA/ROCK, which could have important implications in brain inflammatory disorders.

1 January 2011 in Neurosignals
Verified
Journal Article
Closed access
PDF file
LNL. Nguyen
L. Nguyen
NRN.J. Rothwell
N.J. Rothwell
EPEmmanuel Pinteaux
Emmanuel Pinteaux
Hervé BoutinHervé Boutin
Hervé Boutin
Interleukin (IL)-1 is an important neuroimmunomodulator and a key mediator of inflammation during brain disorders. It acts on neuronal and glial cells via binding to the IL-1 type 1 receptor and IL-1 receptor accessory protein (IL-1RAcP). More recently, a neuronal-specific isoform of IL-1RAcP, named IL-1RAcPb, has been identified. Our aim was to determine the role of IL-1RAcPb in IL-1 actions in neuronal and glial cells, and to further explore the signaling mechanisms of IL-1 in neurons. We found that IL-1RAcPb deletion had no effect on IL-1α- and IL-1β-induced activation of the extracellular signal-regulated kinase 1/2 or IL-6 release in glial cultures, although IL-6 release in response to high IL-1α concentration (30 IU/ml) was significantly reduced. We identified the p38 kinase as a key signaling element in IL-1α- and IL-1β-induced IL-6 synthesis and release in neuronal cultures. IL-1RAcPb deletion had no effect on IL-1α- and IL-1β-induced IL-6 release in neurons, but significantly reduced IL-1α- but not IL-1β-induced p38 phosphorylation. Our data demonstrate that the p38 signaling pathway plays an important role in IL-1 actions in neurons, and that IL-1RAcP may regulate some, but not all, neuronal activities in response to IL-1α.

28 April 2014 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
TMTamer M.A. Mohamed
Tamer M.A. Mohamed
MZMin Zi
Min Zi
SPSukhpal Prehar
Sukhpal Prehar
AMArfa Maqsood
Arfa Maqsood
RARiham Abou-Leisa
Riham Abou-Leisa
DODelvac Oceandy
Delvac Oceandy
Tumour necrosis factor-α (TNF-α) plays a key role in the regulation of cardiac contractility. Although cardiomyocytes are known to express the TNF-α receptors (TNFRs), the mechanism of TNF-α signal transmission is incompletely understood. The aim of this study was to investigate whether the tumour suppressor Ras-association domain family protein 1 isoform A (RASSF1A) modulates TNF-α signalling in cardiomyocytes. We used RASSF1A knockout (RASSF1A−/−) mice and wild-type (WT) littermates in this study. Acute stimulation with a low dose of TNF-α (10 µg/kg iv) increased cardiac contractility and intracellular calcium transients' amplitude in WT mice. In contrast, RASSF1A−/− mice showed a blunted contractile response. Mechanistically, RASSF1A was essential in the formation of the TNFR complex (TNFRC), where it functions as an adaptor molecule to facilitate the recruitment of TNFR type 1-associated death domain protein and TNFR-associated factor 2 to form the TNF-α receptor complex. In the absence of RASSF1A, signal transmission from the TNF-α receptor complex to the downstream effectors, such as cytoplasmic phospholipase A2 and protein kinase A, was attenuated leading to the reduction in the activation of calcium handling molecules, such as L-type Ca2+ channel and ryanodine receptors. Our data indicate an essential role of RASSF1A in regulating TNF-α signalling in cardiomyocytes, with RASSF1A being key in the formation of the TNFRC and in signal transmission to the downstream targets.

28 September 2009 in Future Neurology
Verified
Journal Article
Closed access
KCKatie Chapman
Katie Chapman
CDCaroline Drake
Caroline Drake
AGAndrew Greenhalgh
Andrew Greenhalgh
SLSophie Leow-Dyke
Sophie Leow-Dyke
LNLoan Nguyen
Loan Nguyen
EPEmmanuel Pinteaux
Emmanuel Pinteaux